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Abstract 
Recent studies suggest that pro-inflammatory type M1 macrophages inhibit tumor progression and 
that anti-inflammatory M2 macrophages enhance it. The aim of this study was to examine the 
interaction of type M1 and M2 macrophages with pancreatic cancer cells. We studied the migra-
tion rate of fluorescein stained pancreatic cancer cells on Matrigel cultured alone or with Gran-
ulocyte-Macrophage Colony Stimulating Factor (GM-CSF) differentiated macrophages or with 
Macrophage Colony Stimulating Factor (M-CSF) differentiated macrophages, skewing the phe-
notype towards pro- and anti-inflammatory direction, respectively. Macrophage differentiation 
was assessed with flow cytometry and the cytokine secretion in cell cultures with cytokine array. 
Both GM-CSF and M-CSF differentiated macrophages increased the migration rate of primary 
pancreatic adenocarcinoma cell line (MiaPaCa-2) and metastatic cell line (HPAF-II). Stimulation 
with IL6 or IL4+LPS reversed the macrophages’ increasing effect on the migration rate of Mi-
aPaCa-2 completely and partly of HPAF-II. Co-culture with MiaPaCa-2 reduced the inflammatory 
cytokine secretion of GM-CSF differentiated macrophages. Co-culture of macrophages with 
pancreatic cancer cells seem to change the inflammatory cytokine profile of GM-CSF differentiated 
macrophages and this might explain why also GM-CSF differentiated macrophages promoted the 
invasion. Adding IL6 or IL4+LPS to the cell culture with MiaPaCa-2 and GM-CSF or M-CSF dif-
ferentiated macrophages increased the secretion of inflammatory cytokines and this could con-
tribute to the reversion of the macrophage induced increase of cancer cell migration rate. 
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Introduction 
Ductal adenocarcinoma is the most common 
malignancy of the pancreas and worldwide pancreatic 
cancer is among the deadliest forms of cancer. It typ-
ically metastases aggressively at early stages and has 
an overall 5-year survival rate of only 8% [1]. The 
preliminary step for the process of metastasis is usu-
ally invasion through the extracellular matrix (ECM). 
Chronic inflammation, such as in chronic pancreatitis, 
significantly increases the risk of cancer [2,3] and 
lately the relationship between inflammation and 
cancer has been a subject of great interest.  
Monocytes are among the first cells to infiltrate a 
damaged tissue where they differentiate into mature 
macrophages. In response to cytokines and other 
stimuli of their micro-environment macrophages po-
larize towards either pro-inflammatory type 1 (M1) or 
anti-inflammatory type 2 (M2) macrophages [4,5]. M1 








mune system and inhibit tumor progression. Their 
phenotype is generally characterized by high inter-
leukin (IL) 12 and IL23 and low IL10. M2 macro-
phages promote tissue remodeling and repair and 
activate angiogenesis. They enhance wound healing 
by suppressing the immune system. M2 macrophages 
are characterized by a low IL12 and IL23 and high 
IL10 phenotype [6,7]. This distinction is a simplified 
view of the two extremes of the continuum of mac-
rophage polarization and due to their plasticity even 
mature macrophages can alter their polarization.  
In the presence of cancer cells macrophages dif-
ferentiate into tumor associated macrophages (TAMs) 
which is a distinct subpopulation of M2 polarized 
macrophages [6]. In various forms of cancers, includ-
ing the pancreatic cancer, the presence of TAMs is 
associated with a worse prognosis [8]. TAMs increase 
the invasion of pancreatic cancer cells in cell cultures 
and in mouse models [9,10]. They facilitate cancer 
invasion e.g. by producing mediators that degrade the 
ECM, thus, allowing tumor growth and enabling the 
tumor cells to migrate through tissue barriers [9,11].  
In in vitro -studies Granulocyte-Macrophage 
Colony Stimulating Factor (GM-CSF) and Macro-
phage Colony Stimulating Factor (M-CSF) have been 
used to polarize maturing monocytes towards type 
M1 and M2 macrophages, respectively [7,12,13]. Dif-
ferent additional stimuli are used to skew the polari-
zation towards different subtypes of M1 and M2 
macrophages [14]. IL6 is an inflammatory cytokine 
released by pro-inflammatory M1 macrophages [15]. 
It activates STAT-3 pathway that is associated with 
inflammation-induced tumorigenesis [16]. Lipopoly-
saccharide (LPS) activates the classical way via 
toll-like receptor that skews the macrophage polari-
zation towards M1 and increases for example the ex-
pression of Tumor Necrosis Factor alpha (TNFα) in 
macrophages [17]. T-helper (Th) 2 cytokine IL4 acti-
vates monocytes to polarize towards the alternative 
M2 macrophages [18].  
The aim of this study was to examine the relation 
of pro- and anti-inflammatory macrophages with the 
invasiveness of pancreatic cancer. We wanted to find 
ways to interfere with pancreatic cancer cell migration 
through macrophage polarization. The hypothesis 
was that GM-CSF skews the macrophage polarization 
towards M1 and M-CSF towards M2 macrophages. To 
explore the macrophage plasticity we intended to 
stimulate GM-CSF differentiated macrophages fur-
ther towards pro-inflammatory phenotype by adding 
IL6 to the cell culture and to generate a mixed phe-
notype between M1 and M2 to M-CSF differentiated 
macrophages by adding anti-inflammatory IL4 and 
pro-inflammatory LPS. We explored the changes in 
pancreatic cancer cell migration, intercellular cytokine 
signaling and in the macrophages’ surface expression. 
The aim was to change the macrophage polarization 
after their maturation to assess their potential in inhi-
bition of pancreatic cancer migration.  
Materials and methods 
Cell cultures and reagents 
Human mononuclear cells were isolated from 
five different healthy subjects' blood samples by den-
sity gradient centrifugation with Ficoll-Paque Plus 
(Amershamn, Uppsala, Sweden). This was followed 
by paramagnetic bead separation with Human Mon-
ocyte Isolation Kit II (Miltenyi Biotec, Auburn, USA) 
according to the manufacturer’s instructions. Blood 
samples from different individuals were processed 
and used in assays separately. Macrophages from the 
same donor were used as internal controls in each of 
the study settings.  
All cells were cultured in Macrophage Se-
rum-free Media (Gibco Life Technologies, Paislay, 
UK) supplemented with penicillin (Sigma, St.Louis, 
USA) 100 mg/ml. To differentiate the isolated mon-
ocytes into mature macrophages we added GM-CSF 
(ImmunoTools, Oldenburg, Germany) 10 ng/ml or 
M-CSF (ImmunoTools) 50 ng/ml to the culture media 
and incubated them in standard 37 ºC and 5 % CO2 
for 5 days. The additional stimuli, LPS 10 ng/ml 
(Sigma) and IL4 20 ng/ml (R&D Systems, Shanghai, 
China) or IL6 50 ng/ml (R&D Systems), were added 
after 5 days of monocyte differentiation.  
The human pancreatic adenocarcinoma cell lines 
MiaPaCa-2 (primary tumor cell line) and HPAF-II 
(metastatic tumor cell line) were purchased from the 
American Type Culture Collection. MiaPaCa-2 and 
HPAF-II were either cultured alone using the same 
media as for the macrophages or added to the mac-
rophage cultures after 5 days of monocyte isolation 
and differentiation. The study has been approved by 
Ethics Committee of Helsinki University Central 
Hospital. 
Macrophage characterization 
To assess the surface expression of the differen-
tiated macrophages they were cultured on Nunc Up-
Cell dishes (Thermo Scientific). First, the isolated 
monocytes were differentiated into macrophages with 
GM-CSF or M-CSF for 5 days. Then the additional 
stimuli IL4 + LPS/IL6 and/or MiaPaCa-2 cells or 
neither were added and the cells were cultured for 
further 48 hours. The cells were detached from the 
UpCell dishes according to the manufacturer’s in-
structions by incubating the cells in room temperature 
for 40 minutes. After detaching the cells, macrophages 
were separated from the cancer cells with anti-CD11b 
magnetic micro beads (Miltenyi Biotec Inc., Auburn, 




USA) and labeled with selected antibodies for 20min 
in room temperature. They were acquired on FACS 
Calibur (CellQuest Pro software; BD Bioscience) flow 
cytometer and the data was analyzed with WinMDI 
software (v2.8). The antibodies we used were Mouse 
Anti-Human FITC and PE CD14, FITC CD16, PE 
CD80, APC CD86, PE CD163, APC CD206, PE CD209, 
PE Mouse IgG1 κ Isotype Control, APC Mouse IgG1 κ 
Isotype Control, FITC Mouse IgG1 κ Isotype Control 
(BD Pharmingen, San Diego, USA). 
Cancer cell migration study 
Cells were cultured on 8-well coverslip dishes 
(Nunc, Thermo Scientific, Rochester, USA) coated 
with 60 μl Matrigel (BD Biosciences, San Jose, USA). 
As described, the monocytes were first differentiated 
into macrophages with GM-CSF or M-CSF on Mat-
rigel for 5 days, after which the additional stimuli 
IL4+LPS or IL6 were added. Simultaneously was 
added MiaPaCa-2 and HPAF-II cells, which were 
stained with fluorescent dye (CellTracker Green 
CMFDA, Invitrogen, Eugene, USA). We let the cells 
settle in a standard cell incubator for 24 hours before 
the fluorescence microscopy.  
The cancer cell migration on Matrigel was as-
sessed by recording their movement with 30 min in-
tervals for 24 hours in fluorescence microscope 
equipped with coolled CCD camera (Sensicam, PCO, 
Germany) and humidified, temperature (+37 ºC) and 
CO2 (5 %) controlled chamber (OKOlab, Ottaviano, 
Italy), as previously described [19]. The data was an-
alyzed using ImagePro software (v 7.01, Media Cy-
bernetics, Rockville, MD, USA). The stained cancer 
cells were observed with and without the presence of 
the differentiated macrophages and the stimuli IL4 + 
LPS or IL6. 
Cytokine array 
For the cytokine array the monocytes were first 
differentiated into macrophages for 5 days with cul-
ture media supplemented with either GM-CSF or 
M-CSF. At this point, the media was refreshed in all 
cell cultures and the additional stimuli (IL4 + LPS for 
M-CSF stimulated cells and IL6 for GM-CSF stimu-
lated cells) and/or MiaPaCa-2 cells were added to the 
cell cultures. After 24 hours of incubation in standard 
37 ºC and 5 % CO2 incubator, the cell culture media 
was collected. The collected medium was concen-
trated from 1.5 ml by 3K filters (Amicon Ultra Cen-
trifugal Units, Millipore Corporation, Billerica, MA, 
USA). The concentrated medium was incubated with 
pre-coated Human Cytokine Array Panel A (Proteo-
me Profiler Arrays, R&D Systems) according to the 
manufacturer’s instructions. The arrays were imaged 
with the Odyssey infrared imager (Licor Biosciences, 
Lincoln, USA). The dot blots were analyzed densito-
metrically with Odyssey software (Licor Biosciences).  
 Statistics  
To detect the difference between continuous 
variables we used the nonparametric Mann-Whitney 
U test or Wilcoxon’s signed-rank test (paired meas-
urements). p values <0.05 were considered statisti-
cally significant. The results are presented as mean ± 
standard error of mean (SEM). In the migration assay 
confidence intervals (CI) for fold change were calcu-
lated according to the rules of error propagation as 
asymptotic confidence intervals. Cytokine array re-
sults are given as percentage between negative and 
positive control recorded on each array. 
Results 
Macrophage characteristics  
We used several surface markers (M1 markers: 
CD16, CD80, CD86 and M2 markers: CD14, CD163, 
CD206, CD209) to characterize the differentiated 
macrophages using flow cytometry (Fig. 1). When 
comparing GM-CSF and M-CSF differentiated mac-
rophages the proportion of macrophages positive to 
M2 markers CD209 (p=0.004), CD163 (p=0.001), and 
CD14 (p=0.007) was greater in M-CSF differentiated 
macrophages but M2 marker CD206 was conversely 
less positive (p=0.001). Of M1 markers the only sig-
nificant difference was that the proportion of macro-
phages positive to CD80 was greater in M-CSF dif-
ferentiated macrophages (p=0.017). These findings 
show that GM-CSF differentiated macrophages are 
only slightly more polarized towards M1 (as the ma-
jority of M2 markers are lower in these macrophages) 
and M-CSF differentiated macrophages towards M2 
but they also show that the division isn’t unambigu-
ous. Co-culturing MiaPaCa-2 with GM-CSF differen-
tiated macrophages increased the CD16 positivity of 
the macrophages (p=0.002). MiaPaCa-2 cells did not 
induce significant changes in M-CSF differentiated 
macrophages’ surface expression.  
Adding IL4 + LPS to M-CSF differentiated mac-
rophages increased the expression of M2 markers 
CD209 (p=0.001) and CD206 (p=0.005) whereas the 
expression of M2 markers CD163 (p=0.001) and CD14 
(p=0.007) decreased and M1 marker CD16 increased 
(p=0.022) (Fig. 1). When MiaPaCa-2 cells were added 
to M-CSF + IL4 + LPS differentiated macrophages the 
increased proportion of cells positive to CD206 
(p=0.008) and decreased CD163 (p=0.008) and CD14 
(p=0.004) positivity. Adding IL6 induced no statisti-
cally significant differences to the surface expression 
of GM-CSF differentiated macrophages with nor 
without MiaPaCa-2.  
 




IL6 and IL4 + LPS reversed the macro-
phage-induced increase of pancreatic cancer 
cell migration 
Both GM-CSF and M-CSF differentiated macro-
phages increased the migration rate of pancreatic 
cancer cells in Matrigel. GM-CSF differentiated mac-
rophages increased the migration rate of primary 
pancreatic adenocarcinoma tumor cell line (Mi-
aPaCa-2) from 11.4μm/h ± 1.0 to 24.1μm/h ± 1.7 
(p<0.001, increase 2.1 fold (95% CI 1.6-2.6)) and meta-
static cell line (HPAF-II) from 4.7μm/h ± 0.4 to 
18.4μm/h ± 2.5 (p<0.001, increase 3.9 fold (95% CI 
2.7-5.1)). M-CSF differentiated macrophages increased 
the migration rate of MiaPaCa-2 cells from 11.4μm/h 
± 1.1 to 16.7μm/h ± 1.6 (p=0.011, increase 1.5 fold 
(95% CI 1.1-1.9)) and of HPAF-II from 5.5μm/h ± 0.8 
to 20.9μm/h ± 1.4 (p<0.001, increase 3.8 fold (95% CI 
2.6-5.0)). GM-CSF differentiated macrophages in-
creased the migration rate of MiaPaCa-2 cells unex-
pectedly slightly more than M-CSF differentiated 
macrophages (p=0.007). (Fig. 2) 
 
Figure 1. GM-CSF (skewed towards M1) and M-CSF (skewed towards M2) differentiated macrophages expressed different surface protein distribution in flow cytometry. 
Comparing GM-CSF and M-CSF macrophages proportion of cells positive to M2 markers CD209, CD163 and CD14 was significantly higher in M-CSF differentiated macrophages 
but M2 marker CD206 was less positive and also M1 marker CD80 was higher (#p<0.05). This shows a partly incomplete polarization with these commonly used stimulants. 
MiaPaCa-2 cells increased only the CD16 positivity of GM-CSF macrophages but had no significant effect on M-CSF differentiated macrophages. IL6 induced no significant changes 
to the surface expression of GM-CSF differentiated macrophages. Adding IL4 and LPS to M-CSF differentiated macrophages increased the proportion of cells positive to M2 
markers CD209 and CD206 and to M1 marker CD16 but M2 markers CD163 and CD14 decreased (*p<0.05). Error bars show the standard error of mean. 
 
Figure 2. Both GM-CSF and M-CSF differentiated macrophages increased the migration rate of pancreatic cancer cells. This could be reversed by adding IL6 to GM-CSF or IL4 
and LPS to M-CSF differentiated cell culture. MiaPaCa-2 and HPAF-II cell invasion rate was measured in Matrigel cultured alone and with macrophages when they were cultured 
in medium containing (A) GM-CSF with and without IL6 and (B) M-CSF with and without IL4 and LPS. Error bars show the standard error of mean. *p<0.05. 




The additional stimuli IL6 and IL4 + LPS de-
creased the macrophage-induced invasiveness of 
pancreatic adenocarcinoma cells. When the cancer 
cells and macrophages were differentiated with 
GM-CSF + IL6 the migration rate of MiaPaCa-2 cells 
was 12.3μm/h ± 0.9 (2.0 fold decrease compared to 
MiaPaCa-2 cells co-cultured with macrophages dif-
ferentiated with only GM-CSF (95% CI 1.6-2.4), 
p<0.001) and of HPAF-II cells it was 13.2μm/h ± 0.7 
(1.4 fold decrease compared to HPAF-II cells 
co-cultured with macrophages differentiated with 
GM-CSF (95% CI 1.0-1.8), p=0.044). The migration rate 
of MiaPaCa-2 cells co-cultured with M-CSF + IL4 + 
LPS differentiated macrophages was 10.2μm/h ± 1.1 
(1.6 fold decrease compared to MiaPaCa-2 cells and 
macrophages differentiated with M-CSF (95% CI 
1.2-2.1), p=0.003) and of HPAF-II cells it was 9.8μm/h 
± 1.1 (2.1 fold decrease compared to HPAF-II cells and 
macrophages differentiated with M-CSF (95% CI 
1.6-2.7), p=0.007). The additional stimuli IL6 and IL4 + 
LPS induced no significant changes to the migration 
rate of the pancreatic cancer cells cultured without 
macrophages. 
IL6 and IL4 + LPS increased the inflammatory 
cytokine response in co-cultures of pancreatic 
cancer cells and macrophages 
The cytokine panel searched the cell culture me-
dium for numerous different cytokines and here we 
discuss only the statistically significant changes that 
we found. GM-CSF differentiated macrophages 
co-cultured with MiaPaCa-2 cells released less in-
flammatory cytokines TNFα (p=0.018) and IL23 
(p=0.005) than the GM-CSF differentiated macro-
phages cultured alone and simultaneously decreased 
the secretion of anti-inflammatory IL13 (p=0.010) and 
IL-1Ra (interleukin 1 receptor antagonist, p<0.001). 
Adding IL6 to GM-CSF differentiated cell culture with 
macrophages and MiaPaCa-2 cells increased the ex-
pression of inflammatory cytokines TNFα (p=0.001), 
IL23 (p=0.004), and CCL1 (p=0.033). (Fig. 3. a) 
 
 
Figure 3. Cytokine secretion of macrophages and pancreatic cancer cells was studied with cytokine array. These figures show only the cytokines where significant changes 
observed on the array panel. (A) When GM-CSF differentiated macrophages were co-cultured with pancreatic cancer cells their inflammatory cytokine secretion decreased 
significantly. When IL6 was added to the cell culture the inflammatory cytokine secretion was restored. (B) In M-CSF differentiated macrophages co-cultured with pancreatic 
cancer cells stimulation with IL4 and LPS activated the secretion of inflammatory cytokines. Error bars show the standard error of mean. *p<0.05 




Co-culture with MiaPaCa-2 cells decreased the 
secretion of IL-1Ra of M-CSF differentiated macro-
phages (p=0.007). Adding IL4+LPS to the cell culture 
with M-CSF differentiated macrophages and Mi-
aPaCa-2 cells increased the expression of IL6 
(p=0.033), CCL1 (p=0.035), CCL3 (p=0.042), CCL4 
(p=0.027), CCL5 (p=0.045), INFγ (p=0.045), and TNFα 
(p<0.001). (Fig. 3. b) 
Discussion 
Inflammation and the cells associated with it 
play a critical role in formation and progression of 
cancer. Our study endorses the fact that macrophages 
have a drastic impact on pancreatic cancer cell migra-
tion and that their effect can be influenced even after 
their maturation. This study demonstrated that in 
Matrigel, simulating the in vivo extra cellular matrix 
environment, the migration of pancreatic cancer cells 
increased in the presence of both GM-CSF differenti-
ated and M-CSF differentiated macrophages. By 
adding IL6 to GM-CSF differentiated and IL4 + LPS to 
M-CSF differentiated co-cultures we were able to re-
duce the macrophage-induced increase in pancreatic 
cancer cell migration and increase the overall in-
flammatory cytokine profile in the co-culture. 
 In previous studies GM-CSF differentiated 
macrophages have displayed superior ability in sup-
pressing tumor proliferation as compared to M-CSF 
differentiated macrophages [14]. Our study questions 
the assumption that GM-CSF differentiated macro-
phages solely inhibit tumor progression as they in-
creased the migration rate of pancreatic cancer cells. It 
was evident that in our study the macrophages’ cell 
surface expression was not completely skewed to the 
extremes of macrophage polarization as some M2 
markers were higher in GM-CSF differentiated mac-
rophages than in M-CSF differentiated macrophages 
and vice versa. Furthermore, the pancreatic cancer 
cells and the additional stimuli induced surprisingly 
little change to the macrophages’ surface protein ex-
pression. This might result from the study setting as 
GM-CSF and M-CSF were present in the macrophage 
culture from the beginning of monocyte maturation 
and the additional stimuli and pancreatic cancer cells 
were added later. This suggests also that the distinc-
tion of macrophages to type M1 and type M2 accord-
ing to their surface protein expression can be unrelia-
ble in predicting their effect on the pancreatic cancer 
migration, as the additional stimuli didn’t change the 
macrophage polarization according to their surface 
expression but still their influence to the pancreatic 
cancer cell migration was altered. Also in some pre-
vious studies TAMs have shown ability to promote 
tumor invasion regardless of their phenotypic polar-
ization to M1 macrophages with GM-CSF [20,21].  
A possible explanation for the enhancement of 
pancreatic cancer cell migration rate with GM-CSF 
differentiated macrophages was revealed in cytokine 
array: pancreatic cancer cells were able to reduce the 
GM-CSF differentiated macrophages’ inflammatory 
cytokine secretion while the surface expression of 
these macrophages remained substantially intact. 
Previous studies have shown that due to their plastic-
ity mature macrophages change their cytokine secre-
tion in response to interaction with pancreatic cancer 
cells [22]. When the cells were differentiated with a 
combination of GM-CSF + IL6 or M-CSF + IL4 + LPS 
the macrophages’ increasing effect on the migration 
rate of primary pancreatic cancer cell line was almost 
completely reversed and significantly reduced in the 
metastatic cell line. Cytokine array illustrated that the 
additional stimuli elevated the inflammatory cytokine 
and chemokine secretion in the co-culture. In this 
study IL6 with GM-CSF and the combination of an-
ti-inflammatory IL4 and pro-inflammatory LPS with 
M-CSF appeared to skew the macrophage function 
towards pro-inflammatory and anti-tumor direction.  
In both GM-CSF and M-CSF differentiated 
macrophages the secretion of interleukin 1 receptor 
antagonist (IL-1Ra) was significantly reduced when 
co-cultured with pancreatic cancer cells, suggesting 
an inflammatory response towards pancreatic cancer 
cells. IL-1Ra binds to IL1 receptor without activating 
it. IL1α and IL1β are inflammatory cytokines that 
have been associated with metastasis worse prognosis 
in many types of cancer [23]. Interestingly, in our 
study the secretion of IL1α and IL1β remained low in 
all cell cultures (data not shown). Of the cytokines 
observed TNFα and IL23 were elevated by the addi-
tional stimuli in both GM-CSF and M-CSF differenti-
ated co-cultures. The weakness of this setting is ob-
viously that we cannot determine if the increased cy-
tokine secretion originates from macrophages or 
pancreatic cancer cells. TNFα is a cytokine that par-
ticipates in inflammation, immunity, stimulation of 
growth factor synthesis, and apoptosis. It conducts a 
delicate balance between cytotoxicity and growth 
promotion and produces both pro- and anti-tumor 
effects [24]. In pancreatic cancer the clinical use of 
single TNFα treatment does not improve prognosis 
[25]. IL23 is one of the inflammatory cytokines char-
acteristically secreted by pro-inflammatory M1 mac-
rophages [6,7]. It is pivotal in autoimmune and 
chronic inflammation [26]. Its role in tumor progres-
sion is controversial but studies suggest that it is as-
sociated with increased cancer metastasis [27].  
In the M-CSF differentiated co-cultures the ad-
dition of IL4 + LPS increased additionally the secre-
tion of inflammatory IL6, C-C chemokine ligand 
(CCL) 1, CCL3, CCL4, CCL5, and INFγ. The role of 




CCL1, CCL5 (also known as Regulated upon Activa-
tion, Normal T-cell Expressed, and Secreted, 
RANTES), a target gene of NF-κB, and CCL3 (also 
known as Macrophage Inflammatory Protein 1 alpha, 
MIP-1α), CCL4 (MIP-1β) is still unclear in pancreatic 
cancer progression. They are in central role in induc-
ing anti-tumorigenic immune responses but they are 
also associated with progression and metastasis in 
some types of cancer [28,29].  
Due to the complexity of the interactions of 
stromal elements in cancer surroundings in vivo these 
cytokines could have different effects on pancreatic 
cancer migration when exposed to other cells in-
volved in inflammatory interactions, for example, the 
tumor-promoting actions of IL23 via Th-17 cells [30]. 
We do not suggest that these individual inflammatory 
cytokines by themselves inhibit the migration of pan-
creatic cancer cells but our study demonstrates the 
overall enhancement of the inflammatory status of 
macrophages and their microenvironment seem to 
inhibit pancreatic cancer cell migration in Matrigel. 
This needs further investigation in future studies. 
Both GM-CSF and M-CSF differentiated macro-
phages increased the migration rate of metastatic 
pancreatic cancer cell line markedly more than of the 
primary tumor cell line. Further, with the metastatic 
cell line the macrophages’ increasing effect on the 
migration rate was only partly reversed by the com-
bination of GM-CSF + IL6 or M-CSF + IL4 + LPS. The 
metastatic cell line seems to have developed mecha-
nisms to take more advantage of TAMs’ tumor pro-
moting abilities and ways to resist the inflammatory 
response. Previous studies have shown similar ob-
servations; hypoxia does not inhibit macro-
phage-induced migration in metastatic pancreatic 
cancer cells as it does in primary tumor cells and the 
expression of for example ADAM8, TIMP3, Vaso-
hibin-1, VEGF-A, and VEGF-C is different in meta-
static and primary tumor cell lines [9,31]. However, as 
we used only one primary and one metastatic cell line 
our results need to be confirmed in future studies.  
As this is an in vitro study it is impossible to 
draw direct conclusions to in vivo situation. It would 
be beneficial to study the relevance of these findings 
in enhancing the inflammatory status of macrophages 
in in vivo models. Since macrophages participate es-
sentially in pancreatic cancer invasion and the cancer 
cells are able to influence macrophage polarization 
and cytokine expression even after their maturation it 
is crucial to find ways to enhance the inflammatory 
competence of macrophages and further study their 
utility as potential targets for therapy.  
Conclusion 
Macrophages participate indisputably to pan-
creatic cancer cell invasion and understanding these 
interactions is essential for the development of pan-
creatic cancer treatment. Pancreatic cancer cells are 
able to inhibit inflammatory cytokine expression in 
GM-CSF differentiated macrophages. This explains 
why both GM-CSF (skewed towards 
pro-inflammatory M1) and M-CSF (skewed towards 
anti-inflammatory M2) differentiated macrophages 
promoted the invasion of pancreatic cancer cells. IL6 
and IL4+LPS activated the inflammatory cytokine 
expression in the cell cultures and this could contrib-
ute to the reversion of the macrophage induced in-
crease in cancer cell migration rate. Further studies 
are needed to apply these findings to the in vivo situ-
ation. 
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